Fonix secures six new PowerScribe contracts

Article

Fonix secures six new PowerScribe contractsDictation software developer Fonix of Salt Lake City last month signed contracts with six U.S. hospitals for its PowerScribe Radiology speech recognition/dictation system. Fonix licensed the system to

Fonix secures six new PowerScribe contracts

Dictation software developer Fonix of Salt Lake City last month signed contracts with six U.S. hospitals for its PowerScribe Radiology speech recognition/dictation system. Fonix licensed the system to Shands Medical Center in Gainesville, FL, Community General Hospital and Lawrence Hospital in NY, Griffin Hospital in Derby, CT, Citrus Valley Medical Center in Covina, CA, and Ingalls Health System in Cook County, IL. The contracts are worth about $824,000, and Fonix expects to gain additional revenues from ongoing service and maintenance agreements.

The company also announced that it has established a 19-person direct sales and service team in its Healthcare Solutions Group to focus on the PowerScribe product line. Previously part of PowerScribe's North American distributor, The MRC Group, the team captured sales contracts in 1998 totaling $4.1 million. Fonix expects to gain about $2 million of these sales, and will benefit from annual maintenance and service agreements that arise from these and future contracts, according to the Salt Lake City-based firm. Fonix continues to develop PowerScribe Emergency Medicine System and has placed the product in beta sites, according to the company.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.